alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31**CERTIFICATION**I, Ted L. Hall, certify that:     1. I have reviewed this quarterly report on Form 10-Q of Kiewit Royalty Trust, for which U.S.Bank National Association acts as Trustee;     2. Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to the periodcovered by this quarterly report;     3. Based on my knowledge, the financial statements, and other financial information includedin this quarterly report, fairly present in all material respects the financial condition,distributable income and changes in trust corpus of the registrant as of, and for, the periodspresented in this quarterly report;     4. I am responsible for establishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)), or for causing such procedures to beestablished and maintained, for the registrant and I have:     a) designed such disclosure controls and procedures, or caused such controls and procedures tobe designed under my supervision, to ensure that material information relating to the registrant ismade known to me by others within the registrant, particularly during the period in which thisquarterly report is being prepared;     b) evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report my conclusions about the effectiveness of the disclosure controls andprocedures as of the end of the period covered by this report, based on my evaluation; and     c) disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and     5. I have disclosed, based on my most recent evaluation, to the registrant’s auditors:     a) all significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and     b) any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.     In giving the certifications in paragraphs 4 and 5 above, I have relied to the extent Iconsider reasonable on information provided to me by Amber Brewster, Bank of Oklahoma.Date: May15, 2006   /s/ Ted L. Hall Ted L. Hall  Vice President and Trust Officer U.S. Bank National Association, as Trustee  
8
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 1 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 2 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 3 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 4 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 5 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 6 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 7 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 8 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 9 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 10 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 11 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 12 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 13 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 14 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 15 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 16 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 17 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 18 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 19 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 20 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 21 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 22 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 23 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 24 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 25 of 26
USDC IN/ND case 1:13-cv-00146-PPS document 1 filed 03/25/13 page 26 of 26
IN THE SUPREME COURT OF THE STATE OF MONTANA

DA 20-0423

_________________

STATE OF MONTANA,

 Plaintiff and Appellee,

 v.

RICHARD EDWARD ADSIT, JR.,

 Defendant and Appellant.

O R D E R

_________________

Pursuant to the Internal Operating Rules of this Court, this cause is classified for 

submission on briefs to a five-justice panel of this Court. 

The Clerk is directed to provide a copy hereof to all counsel of record and to the 

Honorable Jon A. Oldenburg, District Judge.

For the Court,

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

February 2 2022

02/02/2022

Case Number: DA 20-0423
Michael L. SCHUTTPELZ, petitioner, v. UNITED STATES.

No. 12-9588.

Supreme Court of the United States

May 13, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
Joseph JOHNSON, petitioner, v. UNITED STATES, et al.

No. 12-8617.

Supreme Court of the United States

April 1, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF INDIANA 

SOUTH BEND DIVISION 

RICHARD TALLMAN, 

 Plaintiff, 

 v. 

NEW ENGLAND COMPOUNDING 

PHARMACY, INC. d/b/a NEW 

ENGLAND COMPOUNDING 

CENTER; BARRY AND LISA 

CADDEN; AND GREGORY 

CONIGLIARO, 

 Defendants. 

)

)

)

)

)

)

)

)

)

)

)

)

)

)

 CAUSE NO.: 3:12-cv-741-JD-CAN 

UNOPPOSED MOTION FOR EXTENSION OF TIME

TO RESPOND TO PLAINTIFF’S COMPLAINT

Pursuant to L.R. 6.1., Defendants Barry Cadden, Lisa Cadden and Greg Conigliaro 

(“Defendants”), by counsel, hereby move this Court for an extension of time to respond to 

Plaintiff’s Complaint, up to and including April 22, 2013. Defendants’ Answer is currently due 

February 21, 2013. Plaintiff’s counsel has been consulted and has no objection to the requested 

extension. 

WHEREFORE, Defendants, by counsel, pray for an Order allowing Defendants up to and 

including April 22, 2013 to respond to Plaintiff’s Complaint, and for all other relief just and 

proper in the premises. 

 

case 3:12-cv-00741-JD-CAN document 11 filed 02/14/13 page 1 of 2
2 

LEWIS WAGNER LLP 

By: /s/ Kameelah Shaheed-Diallo 

DINA M. COX, #18590-49 

KAMEELAH SHAHEED-DIALLO, #28058-49 

ROBERT M. BAKER IV, #25471-49 

JANELLE M. KILIES, #30708-49 

 Attorneys for Defendants 

CERTIFICATE OF SERVICE

 This is to certify that a copy of the foregoing has been filed with the Clerk of the Court 

on February 14, 2013 using the CM/ECF system which sent notification of this filing to the 

following: 

Douglas D. Small 

Edmond W. Foley 

FOLEY & SMALL 

1002 East Jefferson Blvd. 

South Bend, IN 46617 

Counsel for Plaintiff 

/s/ Kameelah Shaheed-Diallo 

 KAMEELAH SHAHEED-DIALLO 

LEWIS WAGNER, LLP 

501 Indiana Avenue, Suite 200 

Indianapolis, IN 46202 

Phone: (317) 237-0500 

FAX: (317) 630-2790 

kshaheed-diallo@lewiswagner.com \\lwfilesrv\DOCS\NECC\8 - Tallman\Federal Court Pleadings\2nd_MET.docx

case 3:12-cv-00741-JD-CAN document 11 filed 02/14/13 page 2 of 2
[Federal Register Volume 60, Number 11 (Wednesday, January 18, 1995)]
[Notices]
[Page 3668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1212]



-----------------------------------------------------------------------



NATIONAL FOUNDATION ON THE ARTS AND HUMANITIES

Literary Advisory Panel (Audience Development Section); Notice of 
Meeting

    Pursuant to section 10(a)(2) of the Federal Advisory Committee Act 
(Pub. L. 92-463), as amended, notice is hereby given that a meeting of 
the Literature Advisory Panel (Audience Development Section) to the 
National Council on the Arts will be held on February 14-16, 1995. The 
panel will meet from 9:00 a.m. to 6:00 p.m. on February 14; from 9:00 
a.m. to 6:30 p.m. on February 15; and from 9:00 a.m. to 5:00 p.m. on 
February 16 in room 730, at the Nancy Hanks Center, 1100 Pennsylvania 
Avenue NW., Washington, DC 20506.
    A portion of this meeting will be open to the public from 3:00 p.m. 
to 5:00 p.m. on February 16 for a guideline review and policy 
discussion.
    Remaining portions of this meetings from 9:00 a.m. to 6:00 p.m. on 
February 14; from 9:00 a.m. to 6:30 p.m. on February 15; and from 9:00 
a.m. to 3:00 p.m. are for the purpose of panel review, discussion, 
evaluation, and recommendation on applications for financial assistance 
under the National Foundation on the Arts and the Humanities Act of 
1965, as amended, including information given in confidence to the 
agency by grant applicants. In accordance with the determination of the 
Chairman of February 8, 1994, these sessions will be closed to the 
public pursuant to subsection (c) (4), (6) and (9)(B) of section 552b 
of Title 5, United States Code.
    Any person may observe meetings, or portions thereof, of advisory 
panels which are open to the public, and may be permitted to 
participate in the panel's discussions at the discretion of the Panel 
chairman and with the approval of the full-time Federal employee in 
attendance.
    If you need special accommodations due to a disability, please 
contact the Office of Special Constituencies, National Endowment for 
the Arts, 1100 Pennsylvania Avenue NW., Washington, DC 20506, 202-682-
5532, TTY 202-682-5496, at least seven (7) days prior to the meeting.
    Further information with reference to this meeting can be obtained 
from Ms. Yvonne M. Sabine, Committee Management Officer, National 
Endowment for the Arts, Washington, DC 20506 or call 202-682-5439.

    Dated: January 11, 1995.
Yvonne M. Sabine,
Director, Office of Council and Panel Operations, National Endowment 
for the Arts.
[FR Doc. 95-1212 Filed 1-17-95; 8:45 am]
BILLING CODE 7537-01-M
[Federal Register Volume 60, Number 92 (Friday, May 12, 1995)]
[Notices]
[Page 25737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11788]



[[Page 25737]]

DEPARTMENT OF THE INTERIOR


Dayton Aviation Heritage Commission

AGENCY: National Park Service, Interior.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice sets the schedule for the forthcoming meeting of 
the Dayton Aviation Heritage Commission. Notice of this meeting is 
required under the Federal Advisory Committee Act (Pub. L. 92-463).

MEETING DATE AND TIME: Thursday, June 15, 1995; 2 to 4 p.m.

ADDRESSES: Innerwest Priority Board conference room, 1024 West Third 
Street, Dayton, Ohio 45407.
    This business meeting will be open to the public. Space and 
facilities to accommodate members of the public are limited and persons 
accommodated on a first-come, first-served basis. The Chairman will 
permit attendees to address the Commission, but may restrict the length 
of presentations. An agenda will be available from the National Park 
Service, Midwest Region, 1 week prior to the meeting.

FOR FURTHER INFORMATION CONTACT: William Gibson, Superintendent, Dayton 
Aviation, National Park Service, P.O. Box 9280, Wright Brothers 
Station, Dayton, Ohio 45409, or telephone 513-225-7705.

SUPPLEMENTARY INFORMATION: The Dayton Aviation Heritage Commission was 
established by Public Law 102-419, October 16, 1992.

    Dated: April 28, 1995.
William W. Schenk,
Regional Director, Midwest Region.
[FR Doc. 95-11788 Filed 5-11-95; 8:45 am]
BILLING CODE 4310-70-P
Steven W. CONNER, petitioner, v. COMMISSIONER OF INTERNAL REVENUE.

No. 12-10360.

Supreme Court of the United States

June 24, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Oce of Minority Health

and Health Equity

ESKE OU

TE KONNEN?

Ou ka jere dyabèt ou lè w kenbe sik 

nan san ou nan nivo nòmal atravè 

rejim alimantè, fè egzèsis, oswa lè w 

itilize ensilin oswa medikaman pou 

dyabèt jan founisè swen sante w 

preskri.

Biwo Sante Minorite ak 

Ekite Sante

POU PLIS ENFOMASYON

www.fda.gov/healthequity

healthequity@fda.hhs.gov

1-888-INFO-FDA

(1-888-463-6332)

@FDAHealthEquity

FDA ankouraje patisipasyon 

dives nan esè klinik yo.

Si w panse yon esè klinik ka 

bon pou ou, pale ak founisè 

swen sante w la.

Ou kapab tou chèche esè klinik 

nan zòn ou an nan 

www.clinicaltrials.gov.

DYABET TIP 2
Kisa dyabet tip 2 ye?

Dyabèt tip 2 se yon maladi 

ki rive lè kò ou pa fè 

oswa itilize ensilin 

byen. Ensilin, yon 

òmòn ki fèt pa 

pankreyas la, 

ede glikoz (sik) 

soti nan manje ou 

manje antre nan 

selil yo dwe itilize pou 

enèji. San ensilin, glikoz 

rete nan san ou (wo sik nan 

san) epi li pa rive nan selil ou yo. Apre yon tan, 

dyabèt san kontwòl ka mennen nan lòt pwoblèm 

sante grav tankou maladi kè, maladi ren, ak pedi 

vizyon.

Ki jan yo trete dyabet tip 2?

Objektif tretman dyabèt la se kenbe sik nan san ou 

nan nivo nòmal. Founisè swen sante w la ap 

detèmine objektif sik nan san ou, ranje ou ta dwe 

eseye kenbe osi souvan ke posib, ak konbyen fwa 

pou tcheke sik nan san w lè l sèvi avèk yon mèt 

glikoz (glikomèt) oswa yon monitè glikoz 

kontinyèl.(CGM)

Yon bann sik mande 

pou ou mete yon gout 

san, anjeneral nan 

pwent dwèt ou, nan 

mèt la sou yon bann 

tès jetab pou jwenn 

yon lekti. Yon CGM 

itilize yon sansi glikoz 

mete anba po ou pou 

mezire nivo sik chak kèk 

minit.

Gen kèk moun k ap viv ak dyabèt tip 2 ki ka jere 

maladi yo lè yo chwazi manje ki bon pou sante epi 

yo vin pi aktif fizikman.

Chwazi manje ki bon pou sante. Kle nan jere 

sik nan san se manje manje ki bon pou sante 

nan bon kantite nan bon moman yo. Travay ak 

yon dyetetik oswa yon edikatè dyabèt pou kreye 

yon plan pou manje ki bon pou sante.

Vin pi aktif fizikman. Lè ou aktif ede kò ou itilize 

ensilin efektivman ak pi byen kontwole nivo sik 

nan san ou. Li diminye tou risk pou maladi kè ak 

domaj nè.

•

•

Dyagnostik Nivo A1C

Nomal Anba 5.7%

Pre-dyabet 5.7% rive 6.4%

Dyabet 6.5% oswa pi wo

NIVO A1C OU YO

Tès A1C la mezire mwayèn nivo sik nan san 

ou pandan 3 mwa ki sot pase yo. Pou pifò 

moun k ap viv ak dyabèt, yon rezilta tès 7% 

oswa mwens se ideyal. Nivo A1C ki pi wo 

mete ou nan risk pou konplikasyon dyabèt.

Tcheke nivo A1C ou lè w fè tès omwen de 

fwa pa ane, pi souvan si medikaman w 

chanje oswa si w gen lòt pwoblèm sante.

Anpil moun ki gen dyabèt tip 2 ka bezwen pran 

medikaman pou dyabèt. Sa yo ka gen ladan grenn, 

ensilin, oswa lòt medikaman pou piki.

Si chanjman nan lavi ou yo pa ase pou jere pwa ou, 

operasyon baryatrik se yon opsyon ki ka ede w 

pèdi pwa ak kontwole nivo glikoz ou.

Jere sik nan san ou

Manje ki bon pou sante

Lè w aktif fizikman

Jere tansyon ou

Pa fimen

•

•

•

•

•

DYABET AK SANTE REN OU

Gen dyabèt ogmante risk pou maladi ren 

(nefropati). Kenbe ren ou an bon sante lè w:
BỆNH TIỂU ĐƯỜNG LOẠI 2 LÀ GÌ?

Bệnh tiểu đường loại 2 xảy ra khi cơ thể bạn không sản xuất hoặc sử dụng insulin 

được, khiến lượng đường trong máu cao.

Để biết thêm thông tin về bình đẳng y tế, hãy truy cập www.fda.gov/healthequity.

Chế độ ăn 

uống cân bằng

Quản lý cân

 nặng

Huyết áp bình

thường

Lối sống 

năng động

Giảm nguy cơ mắc bệnh tiểu đường loại 2

Gia tăng

mệt mỏi

Gia tăng khát Nhìn thấy mờ

nước và đi tiểu

Gia tăng cảm

giác đói

Vết loét 

không lành

Giảm cân không rõ 

nguyên do

Các triệu chứng thường phát triển chậm và có 

thể nhẹ. Nhiều người không có triệu chứng.

Bệnh tiểu đường loại 2 thường xảy ra nhất ở người 

trung niên và lớn tuổi nhưng có thể phát triển ở mọi 

lứa tuổi.

BẠN CÓ

BIẾT LÀ ?

CỨ TRONG 10 

NGƯỜI LỚN THÌ CÓ 

KHOẢNG 1 NGƯỜI 

MẮC BỆNH TIỂU 

ĐƯỜNG LOẠI 2 

Không hút

 thuốc
BỆNH TIỂU ĐƯỜNG VÀ NGƯỜI LỚN TUỔI

Bệnh tiểu đường loại 2 xảy ra khi cơ thể bạn không sản xuất hoặc sử dụng insulin

được, khiến lượng đường trong máu cao.

Để biết thêm thông tin về bình đẳng y tế, hãy truy cập www.fda.gov/healthequity.

Ăn uống 

lành mạnh

Không hút

 thuốc

Kiểm soát lượng

đường trong máu

của bạn

Kiểm soát huyết 

áp của bạn

Hoạt động 

thể chất

Dùng thuốc 

theo chỉ định

Giữ cho thận của bạn khỏe mạnh nếu bạn bị tiểu đường bằng cách:

BỆNH TIỂU ĐƯỜNG 

ẢNH HƯỞNG ĐẾN 

1 TRONG 4

NGƯỜI TRÊN 

65 TUỔI

Người lớn tuổi có

tỷ lệ cao nhất bị bệnh 

thận ở giai đoạn cuối liên 

quan đến bệnh tiểu 

đường. Điều này xảy ra khi 

thận của bạn bắt đầu 

không làm việc nữa và 

cần phải lọc máu (loại bỏ 

các chất thải và chất lỏng 

dư thừa ra khỏi cơ thể) 

hoặc ghép thận.

94 ãÖ

Çi
Exhibit 32

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q for the period ended March 31, 2010 (the Report) of Kiewit Royalty
Trust (the Trust), as filed with the Securities and Exchange Commission on the date hereof, I, Luke H. Paladino, the trust officer of U.S. Bank National Association, the trustee of the Trust, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:



|(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------

Date: May 12, 2010



|                                          
|------------------------------------------
|/s/ Luke H. Paladino                      
|Luke H. Paladino, Trust Officer           
|U.S. Bank National Association, as Trustee
Rashid ROY, petitioner, v. DELAWARE.

No. 12-9574.

Supreme Court of the United States

June 3, 2013.

Petition for writ of certiorari to the Supreme Court of Delaware denied.
[Federal Register Volume 60, Number 93 (Monday, May 15, 1995)]
[Notices]
[Page 25897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11871]



-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket No. RP95-281-000]


South Georgia Natural Gas Company; Notice of Proposed Changes in 
FERC Gas Tariff

May 9, 1995.
    Take notice that on May 4, 1995, South Georgia Natural Gas Company 
(South Georgia) tendered for filing as part of its FERC Gas Tariff, 
Second Revised Volume No. 1, the following revised tariff sheets, to be 
effective as of the dates shown below:

June 3, 1995
    Second Revised Sheet No. 21
    Second Revised Sheet No. 104
May 4, 1995
    First Revised Sheet Nos. 66-67
    First Revised Sheet No. 71
    First Revised Sheet No. 74
    First Revised Sheet No. 76
    Second Revised Sheet No. 124

    South Georgia states that the purpose of this filing is to (1) 
eliminate the requirement to submit a prepayment with a request for 
firm transportation service, and (2) comply with the provisions of 
Commission Order No. 577 which revise its Regulations governing non-
posted capacity release transactions.
    South Georgia has requested an effective date of June 3, 1995, for 
the first revision and an effective date of May 4, 1995, the effective 
date of Order No. 577, for the other revision.
    South Georgia states that copies of the filing will be served upon 
its shippers and interested state commissions.
    Any person desiring to be heard or to protest said filing should 
file a motion to intervene or protest with the Federal Energy 
Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C. 
20426, in accordance with Rules 211 and 214 of the Commission's Rules 
of Practice and Procedure (18 CFR 385.211 and 385.214). All such 
motions and protests should be filed on or before May 16, 1995. 
Protests will not be considered by the Commission in determining the 
parties to the proceeding. Any person wishing to become a party must 
file a motion to intervene. Copies of this filing are on file with the 
Commission and are available for public inspection.
Lois D. Cashell,
Secretary.
[FR Doc. 95-11871 Filed 5-12-95; 8:45 am]
BILLING CODE 6717-01-M
In the Matter of Disbarment of Joseph W. WEIGEL.

No. D-2707.

Supreme Court of the United States

May 28, 2013.

Disbarment order entered.
United States Court of Appeals

for the Fifth Circuit

No. 20-40101

Conference Calendar

United States of America, 

Plaintiff—Appellee,

versus

Edgar Efrain Hernandez-Valenzuela, 

Defendant—Appellant.

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 1:19-CR-937-1

Before Graves, Willett, and Duncan, Circuit Judges.

Per Curiam:*

The attorney appointed to represent Edgar Efrain HernandezValenzuela has moved for leave to withdraw and has filed a brief in 

accordance with Anders v. California, 386 U.S. 738 (1967), and United States 

v. Flores, 632 F.3d 229 (5th Cir. 2011). Hernandez-Valenzuela has not filed a 

* Pursuant to 5th Circuit Rule 47.5, the court has determined that this 

opinion should not be published and is not precedent except under the limited 

circumstances set forth in 5th Circuit Rule 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

June 29, 2021

Lyle W. Cayce

Clerk

Case: 20-40101 Document: 00515919678 Page: 1 Date Filed: 06/29/2021
No. 20-40101

2

response. We have reviewed counsel’s brief and the relevant portions of the 

record reflected therein. We concur with counsel’s assessment that the 

appeal presents no nonfrivolous issue for appellate review. Accordingly, 

counsel’s motion for leave to withdraw is GRANTED, counsel is excused 

from further responsibilities herein, and the APPEAL IS DISMISSED. 

See 5th Cir. R. 42.2.

Case: 20-40101 Document: 00515919678 Page: 2 Date Filed: 06/29/2021
James C. MARSHALL, et ux., petitioners, v. COLLIER COUNTY, FLORIDA, et al.

No. 12-6747.

Supreme Court of the United States

April 22, 2013.

Petition for rehearing denied.